News

AbbVie unit wins $56 mln in US patent trial against Botox rival
A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...
Nasdaq9mon
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for ...
--Today, Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of BOTOX ® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting ...
Nasdaq8mon
Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic ... - Nasdaq
IRVINE, Calif., Nov. 7, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, November 20. This holiday ...